Evidence map›Paper›PMID 29311086›Full record

ArticleAntimicrobial agents and chemotherapy2018

Prospective Clinical Trial Assessing Species-Specific Efficacy of Artemether-Lumefantrine for the Treatment of Plasmodium malariae, Plasmodium ovale, and Mixed Plasmodium Malaria in Gabon.

Mirjam Groger, Luzia Veletzky, Albert Lalremruata, Chiara Cattaneo, Johannes Mischlinger, Rella Zoleko-Manego, Lilian Endamne, Anna Klicpera, Johanna Kim, The Nguyen and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Mapping Antimalarial Drug Resistance in Mozambique: A Systematic Review ofInternational journal of molecular sciences · 2024
    Pooled it
  2. Trial
  3. Trial
  4. Tropism ofEmerging microbes & infections · 2026
    Article
  5. Article
  6. Reversal of Chloroquine Resistance inInternational journal of molecular sciences · 2026
    Article
  7. Observational
  8. Ex Vivo Drug Susceptibility ofPathogens (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Co-Infectious Mystery: Why Artemether-Lumefantrine ClearedIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2024
    Article
  12. Article
  13. Genetic diversity ofFrontiers in cellular and infection microbiology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Prospective Clinical and Molecular Evaluation of Potential Plasmodium ovale curtisi and wallikeri Relapses in a High-transmission Setting.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Mirjam GrogerDepartment of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
Luzia VeletzkyDepartment of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
Albert LalremruataInstitut für Tropenmedizin, Universität Tübingen, Tübingen, Germany.
Chiara CattaneoCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Johannes MischlingerDepartment of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
Rella Zoleko-ManegoCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Lilian EndamneCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Anna KlicperaCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Johanna KimCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
The NguyenCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Lena FlohrCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Jonathan RemppisCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Pierre-Blaise MatsieguiCentre de Recherches Médicales de la Ngounie, Fougamou, Gabon.
Ayôla A AdegnikaCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Selidji T AgnandjiCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Peter G KremsnerCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Benjamin MordmüllerInstitut für Tropenmedizin, Universität Tübingen, Tübingen, Germany.
Ghyslain Mombo-NgomaCentre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Michael RamharterDepartment of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria michael.ramharter@meduniwien.ac.at.
Centre de Recherche Médicales de Lambaréné · GAUniversity of Tübingen · DEMedical University of Vienna · ATCentre International de Recherches Médicales de Franceville · GA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment recommendations for

Indexed as

AdolescentAdultAntimalarialsArtemetherChildChild, PreschoolFemaleGabonHumansLumefantrineMalePlasmodium malariaePlasmodium ovaleYoung AdultAntimalarialsArtemetherLumefantrineartemether-lumefantrinemixed Plasmodium malariaPlasmodium malariaePlasmodium ovale

Identifiers

PMID29311086
PMCPMC5826119
OpenAlexW2792093369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.